The risk of lymphoma development in autoimmune diseases: a meta-analysis.

By Elias Zintzaras, M. Voulgarelis, H. Moutsopoulos. Archives of Internal Medicine, 2005

768 citations recorded by the source corpus.

Subfields: Hepatology, Physiology, Rheumatology

View Paper: https://www.semanticscholar.org/paper/5d812840e00f7e8b361ddf0900a7e2daf0c810ad

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. E. Engels
2. A. Grulich
3. M. Falster
4. C. Vajdic
5. K. Ekström Smedby
6. M. Maynadié
7. O. Martínez-Maza
8. A. Seniori Costantini

Citations in the corpus

• Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. (2008, result): “In RA, we did not find an increased risk of NHL overall, unlike most previous reports.(10,11,38) However, a moderately increased NHL risk was observed among RA patients treated with corticosteroids or immunosuppressants, supporting a gradient in risk by treatment or disease severity.”